Skip to content

MDMA: all studies

Page 231 of 345: studies 2,301 to 2,310 of 3,446, newest first. Back to the MDMA overview

Research

Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users

Contemporary Drug Problems September 1, 2019 Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers 50 citations

Novel psychoactive substances (NPS) are compounds designed to mimic the effects of existing recreational drugs (classical psychoactive substances [CPS]), while eluding established legal frameworks. Little is known about their effects and potential harms, rendering the increasing number of NPS a challenge to policy makers and researchers alike. Quantitative studies on the motives underlying NPS...

Psychedelic drugs—a new era in psychiatry?

Dialogues in Clinical Neuroscience June 30, 2019 David Nutt 131 citations

This article covers the renaissance of classical psychedelic drugs such as psilocybin and LSD plus 3,4-methylene dioxymethamphetamine (MDMA-ecstasy) in psychiatric research. These drugs were used quite extensively before they became prohibited. This ban had little impact on recreational use, but effectively stopped research and clinical treatments, which up to that point had looked very...

New psychoactive substances: psychiatrist's view

Interactive science June 21, 2019 Andrey Viktorovich Antsyborov, Irina Vladimirovna Dubatova 1 citation

Appearing not long ago, new psychoactive substances (designer drugs), including synthetic cannabinoids, derivatives of cathinone, phenethylamines, new stimulants, synthetic opioids, tryptamine derivatives, phencyclidine, piperazine, the GABA (A/B) receptors agonists, have become a serious problem for consumers and for physicians. Consumers of these substances are attracted primarily by the...

DOI: 10.21661/r-497066 (opens in new tab) Full text (opens in new tab) MDMA Synthetic cannabinoids Designer drug Cathinone +9

Drugs—without the hot air: minimising the harms of legal and illegal drugs

Practical Neurology June 13, 2019 Charis Wong 1 citation

In the wake of recent changes to legislation on cannabinoid prescribing we decided to discuss Drugs – without the hot air 1 (figure 1) for the latest Edinburgh Neurology Book Club. Written by David Nutt, Professor of Neuropsychopharmacology, this book provides his account of how he became the ‘scientist who was sacked’ by the UK Home Secretary, after comparing the risks of harm from...

DOI: 10.1136/practneurol-2019-002288 (opens in new tab) Ecstasy Cannabis Recreational drug Neuropsychopharmacology +2

Is Psychedelic Medicine on the Horizon?

Psychiatric News February 28, 2019 Nick Zagorski

New research suggests that, if used properly, psychedelic compounds may be able to help patients with treatment-resistant psychiatric disorders. Psychedelic compounds such as LSD and magic mushrooms were the subject of a good deal of psychiatric research in the first half of the 20th century. This all changed in 1970, when President Richard Nixon signed the Controlled Substances Act, which in...

A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State

Journal of Psychoactive Drugs January 24, 2019 Kim P. C. Kuypers, E. B. de Sousa Fernandes Perna, Eef L. Theunissen et al. 13 citations

The phenethylamine 4-fluoroamphetamine (4-FA) is a so-called novel psychoactive substance with a chemical structure resembling that of amphetamine and MDMA. Since 4-FA users report their subjective experience ranges between the effects induced by amphetamine and MDMA, and it is known that both substances can produce an altered state of consciousness, this study tests whether 4-FA induces a...

The professional ecstatic in his social and ritual position

Scripta Instituti Donneriani Aboensis January 16, 2019 Birgitte Sonne

The professional ecstatic is a religious specialist, who has become recognized as a person able to carry out an ecstatic ritual, corresponding with the local cultural expectations in force. The ecstatic ritual per se comprises a number of persons, i.e. it is a collective ritual. Part of the criteria that may be employed as a measure of the professional ecstatic's social status, is covered by...

Spirit lodge, a Northern American shamanistic séance

Scripta Instituti Donneriani Aboensis January 16, 2019 Åke Hultkrantz

The Spirit Lodge is a variety of shamanism characterized by its divining functions. Herein lie its limitations: the shamanistic trance is there, and so are the helping spirits, but the curing activity so typical of shamanism is absent, or principally absent. The act of divining shows a certain affinity with the shamanistic pole-climbing performances and may originally have been related to...

Ecstatic prophecy in the Old Testament

Scripta Instituti Donneriani Aboensis January 16, 2019 Gunnel André

When speaking of prophets in our culture, we usually have the Old Testament classical prophets in mind. At the mention of prophetic ecstasy the immediate reaction is often, "That would be Saul and the asses or Elijah and the prophets of Baal". A sharp distinction is often made between the so-called primitive prophets and the classical prophets. Bearing in mind that the Chronicles mention...

Spirit-possession in theory and practice: séances with Tibetan spirit-mediums in Nepal

Scripta Instituti Donneriani Aboensis January 16, 2019 Per-Arne Berglie

This paper describes a short study of the séances and trance-performances of three Tibetan spirit-mediums (dpa' bo) from a refugee-community in Nepal. The field-work on which this study is based was carried out in a Tibetan refugee-village in Nepal during 1970 and 1971. For each dpa' bo: dBang phyug, Sri gcod, and Nyi ma don grub, a summary of personal thoughts and beliefs concerning possession...